Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial data
Abstract Background There is a need to better reflect the patient experience in multiple myeloma (MM), beyond just clinical progression, with the use of a novel endpoint that combines disease progression with patient-reported outcomes. Methods A systematic literature review (SLR) identified relevant...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2025-08-01
|
| Reeks: | BMC Cancer |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s12885-025-14724-6 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
